Financials
Income statement
Fiscal date | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Total reported revenue | 44.1B | 47.9B | 46.3B | 55.5B |
Cost of revenue | 12.5B | 13.0B | 13.7B | 12.7B |
Gross profit | 31.6B | 34.9B | 32.6B | 42.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 6.5B | 6.3B | 6.2B | 5.9B |
Other operating expenses | 8.7B | 8.9B | 7.5B | 8.8B |
Operating income | 16.4B | 19.7B | 18.9B | 28.0B |
Non operating interest income | ||||
Income | 518.5M | 609.7M | 454.9M | 69.1M |
Expense | 1.6B | 1.9B | 1.8B | 973.9M |
Other income expense | 436.0M | -4.6B | 927.0M | 1.1B |
Pretax income | 15.8B | 13.8B | 18.4B | 28.3B |
Tax provision | 6.2B | 5.5B | 6.1B | 9.2B |
Net income | 9.6B | 8.3B | 12.3B | 28.2B |
Basic EPS | 3.6 | 3.1 | 5.1 | 12.2 |
Diluted EPS | 3.5 | 3.1 | 5.1 | 12.2 |
Basic average shares | 2.2B | 2.2B | 2.2B | 2.2B |
Diluted average shares | 2.2B | 2.2B | 2.2B | 2.2B |
EBITDA | 22.3B | 22.9B | 24.5B | 33.2B |
Net income from continuing op. | 15.8B | 13.8B | 18.4B | 28.3B |
Minority interests | -2.1B | -1.7B | -1.4B | -2.2B |
Preferred stock dividends | — | — | — | — |